Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Infusion Options, Inc.

Infusion Options, Inc. Recalls

All product recalls associated with Infusion Options, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

76

Past Year

0

Class I (Serious)

0

Most Recent

Jun 2019

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 76 recalls

Adcetris 96 MG (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Cetuximab IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Darzalex IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY

Previous

12 3 4

Page 1 of 4Next

• Infusion Options, Inc.

Atezolizumab (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Iron Sucrose Infusion (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

RomiPLOStim Syringe (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Orencia IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Carfilzomib (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Pembrolizumab IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Pertuzumab Infusion (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Granisetron (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Ado-Trastuzumab (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Bleomycin Infusion (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Topotecan 1.24 MG (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Diphenhydramine 25 MG (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Panitumumab IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Fosaprepitant Infusion (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Perjeta 420 MG (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Injectafer 720 MG (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Ondansetron Infusion (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.